胰腺癌的病理学及相关分子生物学研究进展
Recent progresses in pathology and molecular biology in pancreatic cancer
出处
《外科理论与实践》
2005年第3期280-283,共4页
Journal of Surgery Concepts & Practice
二级参考文献73
-
1沈霞 李ND52B.临床免疫学与免疫学检验：第1版[M].北京:人民军医出版社,2002.196-198.
-
2[1]Coppola D, Molecular Prognostic Markers in Pancreatic Cancer: a review.Cancer Control, 2000,7( 5 ) :421-427.
-
3[2]Lynch HT,Smyrk T, Kern SE,et al. Familial pancreatic cancer: a review.Semin. Oncol, 1996,23 ( 2): 251-275.
-
4[3]Lowenfels, A. B. Maisonnevve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cnacer. International Hereditary Pancreatitis Study Group. J. Natl Cancer Inst, 1997,89(6):442-446.
-
5[4]Whitcomb, D. C. Gorry MC, Preston RA, et al. Hereditary pancreatitis is eaused by a mutation in the cationic trypsinogen gene. Nat Genet, 1996,14(2): 141-145.
-
6[5]Capella G,Cronauer-Miza S,Pienado MA,et al. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect, 1991,93:125-131.
-
7[6]Pellegata NS, Sessa F, Renault B, et al. K-ras and P53 gene mutations in pancreatic cancer:ductal and nonductal tumor progress through different genetic lesions. Cancer Res, 1994,54( 6):1556-1560.
-
8[7]Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res, 1994,54( 13):3568-3573.
-
9[8]DiGiuseppe JA, Hruban RH, Offerhaus GJ, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am. J. Pathol, 1994,144(5): 889-895.
-
10[9]Rivera JA,Rall CJ,Graeme-Cook F,et al. Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia. Surgery, 1997,121 (1):42-49.
共引文献9
-
1刘开渊,黄昭穗,罗军宏.CA-199、TSGF联检在胰腺癌诊断中的应用[J].放射免疫学杂志,2005,18(2):154-156. 被引量：8
-
2朱明华.胰腺癌病理学及分子病理学的研究进展[J].第二军医大学学报,2005,26(10):1085-1087.
-
3Li-Sheng Chen Jian-Bao Wei Yong-Chun Zhou Sen Zhang Jun-Lin Liang Yun-Fei Cao Zong-Jiang Tang Xiao-Long Zhang Feng Gao.Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer[J].World Journal of Gastroenterology,2005,11(39):6120-6124. 被引量：12
-
4赵海华,朱明华.胰腺癌相关基因研究进展[J].医学综述,2006,12(5):257-259. 被引量：1
-
5王纯巍,陆星华,刘国仰,戴理,钱家鸣.壶腹周围肿瘤染色体9p21缺失图谱的构建[J].第四军医大学学报,2008,29(18):1689-1691.
-
6王纯巍,陆星华,刘国仰,戴理,徐彤,陈原稼,高春生,温小恒,钱家鸣.Detailed deletion mapping on chromosome region 9p21 in human periampullary neoplasms[J].Chinese Medical Journal,2001(6):28-31.
-
7陶鹏辉.血清CA199检测在胰腺癌诊断和治疗中的应用价值[J].国际检验医学杂志,2009,30(9):914-915. 被引量：4
-
8王纯巍,陆星华.p16基因失活致消化系肿瘤发生的机制[J].胃肠病学,2002,7(3):181-182. 被引量：2
-
9胡思婧,高杉,王杨,刘慧迪.生长抑制因子基因1（ING1）——新型抗癌治疗中的潜在靶点[J].国际遗传学杂志,2018,41(5):378-383. 被引量：2
-
1杨屹,吉士俊,赵国贵.肾积水相关分子生物学研究进展[J].中华泌尿外科杂志,2000,21(6):380-382.
-
2王丽晖.紫癜性肾炎的研究进展[J].国外医学（泌尿系统分册）,1998,18(5):202-205. 被引量：25
-
3房广英,张建民.肾小球肾炎的分子生物学研究进展[J].河北医科大学学报,1998,19(3):190-192. 被引量：1
-
4任力.TNF_α在MsPGN中的作用研究进展[J].空军医高专学报,1997,19(1):36-39.
-
5魏武.缺血再灌注后肾脏损伤及修复的分子生物学研究进展[J].国外医学（泌尿系统分册）,1997,17(4):153-156. 被引量：4
-
6王沙燕,戴勇,李学朝.泌尿系结石分子生物学研究进展[J].中国现代医学杂志,2000,10(6):22-24. 被引量：7
-
7刘锋,张柳,程爱国.骨折愈合的分子生物学研究进展[J].华北煤炭医学院学报,2004,6(4):457-459. 被引量：2
-
8叶亚,赵人瑞.肾小球硬化及其防治的分子生物学研究进展[J].西藏医药,1998,19(2):31-33.
-
9张雷,杨国敬,郑进佑,王珺.非创伤性股骨头缺血性坏死发病机制的分子生物学研究进展[J].中国矫形外科杂志,2008,16(23):1793-1795. 被引量：1
-
10武海军,银和平.椎间盘退变的分子生物学研究进展[J].内蒙古医学杂志,2011,43(7):816-819. 被引量：1
